What is Lexicon Pharmaceuticals's debt repayments?

Lexicon Pharmaceuticals (LXRX) reported debt repayments of $5M in Q1 2026.

What is the long-term trend for Lexicon Pharmaceuticals's debt repayments?

Over 3 years (2021 to 2025), Lexicon Pharmaceuticals's debt repayments has grown at a 60.1% compound annual growth rate (CAGR), from $11.7M to $48M.

What does debt repayments mean?

Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.

Lexicon Pharmaceuticals LXRX Debt Repayments

Debt Repayments at other companies

Eli LillyLLY

$750M—

Merck & Co.MRK

$1.14B-54.4%

CytokineticsCYTK

$2.74M+2.0%

Zevra Therapeutics, Inc.ZVRA

$60.09M—

Opko HealthOPK

$8.88M-7.0%

LQD

Liquidia CorporationLQDA

$19.97M+841%

Other financials

Income statement

See full

Revenue$21.1M+1,572%

Gross profit$21.0M+1,604%

Operating income-$996.0K+96.1%

Net income-$1.0M+95.9%

EPS (diluted)$0.00+100%

Balance sheet

See full

Cash & equivalents$67.1M+6.7%

Total debt$57.7M-45.7%

Total equity$202.9M+64.9%

Total assets$268.8M-9.7%

Cash flow

See full

Operating cash flow-$14.7M+66.4%

CapEx--100%

Free cash flow-$17.2M+21.5%

Valuation

See full

Market cap$986.12M+273%

Enterprise value$976.73M+219%

P/S14.2×+5.7×

Profitability

See full

Gross margin99.5%+1.5pp

Operating margin-34.8%-16.8pp

Net margin-37.5%-18.1pp

FCF margin-578.5%-283pp

Returns & leverage

See full

Return on equity-16%-7.2pp

Debt / equity0.3×-0.6×

Current ratio18.8×+16.6×

Where this comes from

Reported directly by Lexicon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfDebt.

The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lexicon Pharmaceuticals's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lexicon Pharmaceuticals's debt repayments?: Lexicon Pharmaceuticals (LXRX) reported debt repayments of $5M in Q1 2026.
What is the long-term trend for Lexicon Pharmaceuticals's debt repayments?: Over 3 years (2021 to 2025), Lexicon Pharmaceuticals's debt repayments has grown at a 60.1% compound annual growth rate (CAGR), from $11.7M to $48M.
What does debt repayments mean?: Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.